Search Results - Rasmus Jansson-Löfmark

Enantiospecific antitrypanosomal in vitro activity of eflornithine. by Mikael Boberg, Monica Cal, Marcel Kaiser, Rasmus Jansson-Löfmark, Pascal Mäser, Michael Ashton

Connect to this object online.

Establishing a Relationship between In Vitro Potency in Cell-Based Assays and Clinical Efficacious Concentrations for Approved GLP-1 Receptor Agonists by Alessandro Boianelli, Pär Nordell, Joseph Earl, Jacqueline Naylor, David Hornigold, Rasmus Jansson Löfmark, Monika Sundqvist

Connect to this object online.

A case‐study of model‐informed drug development of a novel PCSK9 anti sense oligonucleotide. Part 1: First time in man to phase II by Jane Knöchel, Catarina Nilsson, Björn Carlsson, Linda Wernevik, Alexis Hofherr, Peter Gennemark, Rasmus Jansson‐Löfmark, Rikard Isaksson, Tina Rydén‐Bergsten, Bengt Hamrén, Dinko Rekić

Connect to this object online.

Impact of type 2 diabetes on in vivo activities and protein expressions of cytochrome P450 in patients with obesity by Kine Eide Kvitne, Anders Åsberg, Line K. Johnson, Christine Wegler, Jens K. Hertel, Per Artursson, Cecilia Karlsson, Shalini Andersson, Rune Sandbu, Eva Skovlund, Hege Christensen, Rasmus Jansson‐Löfmark, Jøran Hjelmesæth, Ida Robertsen

Connect to this object online.

Short‐ and long‐term effects of body weight loss following calorie restriction and gastric bypass on CYP3A‐activity - a non‐randomized three‐armed controlled trial by Kine Eide Kvitne, Ida Robertsen, Eva Skovlund, Hege Christensen, Veronica Krogstad, Christine Wegler, Philip Carlo Angeles, Birgit Malene Wollmann, Kristine Hole, Line Kristin Johnson, Rune Sandbu, Per Artursson, Cecilia Karlsson, Shalini Andersson, Tommy B. Andersson, Jøran Hjelmesæth, Rasmus Jansson‐Löfmark, Anders Åsberg

Connect to this object online.